Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

BDF 9148 MeSH Supplementary Concept Data 2025


MeSH Supplementary
BDF 9148
Unique ID
C071117
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C071117
Entry Term(s)
4-(3-((1-(diphenylmethyl)-3-azetidinyl)oxy)-2-hydroxypropoxy)-1H-indole-2-carbonitrile monohydrate
4-(3-(1-diphenylmethylazetidine-3-oxy)-2-hydroxypropoxy)-1H-indole-2-carbonitrile
BDF 9196
BDF-9148
BDF-9196
BDF9196
LY 341311
LY 366634
LY-341311
LY341311
LY366634
Pharm Action
Cardiotonic Agents
Registry Numbers
120838-62-2
CAS Type 1 Name
1H-Indole-2-carbonitrile, 4-(3-((1-(diphenylmethyl)-3-azetidinyl)oxy)-2-hydroxypropoxy)-
Heading Mapped to
*Azetidines
Frequency
39
Note
sodium channel activator; structure given in first source; BDF 9196 - S enantiomer; LY-341311 is the (S)-isomer and monohydrate
Source
Br J Pharmacol 1991;103(4):1939
Date of Entry
1991/10/29
Revision Date
2003/02/24
BDF 9148 Preferred
4-(3-(1-diphenylmethylazetidine-3-oxy)-2-hydroxypropoxy)-1H-indole-2-carbonitrile Broader
BDF 9196 Narrower
LY 366634 Related
LY 341311 Narrower
4-(3-((1-(diphenylmethyl)-3-azetidinyl)oxy)-2-hydroxypropoxy)-1H-indole-2-carbonitrile monohydrate Narrower
page delivered in 0.005s